Recognizing the deficiency of their root.

Mental process Expert Fin's Nexium, marketed as the new chromatic color pill, was nothing more than one of Prilosec's enantiomers. But unlike the antihistamines that had to be withdrawn from the outlet, Prilosec had no John Major side effects. It was even possible action that both of Prilosec's enantiomers became mortal in the appetency. Getting rid of half of the drug would provide no significant clinical benefits for patients. All it provided was a new chemical entity--in physicalness half the old entity--that could be patented separately and submitted to the FDA for blessing.
Recognizing the deficiency of their root, Astra scientists launched a desperate activity for some way to differentiate the Nexium and Prilosec. They authorized four wildly expensive studies comparing the two drugs against erosive esophagitis. If Nexium proved to be a superior drug for that one reading, they would at least earn a unique brand name from the FDA and give visitant detailers some talking points when they were out visiting physicians.